Armo Biosciences Inc (NASDAQ:ARMO)’s Trend Unknown, Especially After Increased Shorts

May 16, 2018 - By John Moody

The stock of Armo Biosciences Inc (NASDAQ:ARMO) registered an increase of 18.7% in short interest. ARMO’s total short interest was 1.29M shares in May as published by FINRA. Its up 18.7% from 1.09M shares, reported previously. With 357,900 shares average volume, it will take short sellers 4 days to cover their ARMO’s short positions.

The stock increased 0.10% or $0.05 during the last trading session, reaching $49.88. About 498,354 shares traded or 30.05% up from the average. ARMO BioSciences, Inc. (NASDAQ:ARMO) has 0.00% since May 16, 2017 and is . It has underperformed by 11.55% the S&P500.

ARMO BioSciences, Inc., an immuno-oncology company, develops a pipeline of novel product candidates that activate the immune system of cancer patients to recognize and eradicate tumors in the United States. The company has market cap of $1.52 billion. The Company’s lead product candidate is AM0010, a long acting form of human interleukin-10 that is in Phase III randomized pivotal clinical trial for the treatment of pancreatic ductal adenocarcinoma. It currently has negative earnings. The firm is also developing AM0010 that has completed Phase I/Ib clinical trial for the treatment of non-small cell lung cancer, renal cell carcinoma, colorectal cancer, and melanoma and breast cancer.

More notable recent ARMO BioSciences, Inc. (NASDAQ:ARMO) news were published by: Fool.com which released: “3 Biotech Stocks That Soared This Week: Are They Buys?” on May 12, 2018, also Nasdaq.com with their article: “Why Spotify Technology, CenturyLink, and ARMO BioSciences Jumped Today” published on May 10, 2018, Bizjournals.com published: “How this biotech nearly tripled its IPO price with a buyout in less than 4 months” on May 10, 2018. More interesting news about ARMO BioSciences, Inc. (NASDAQ:ARMO) were released by: Bizjournals.com and their article: “Big Peninsula biotech buyout means happy returns for Kleiner Perkins, other VCs” published on May 10, 2018 as well as Nasdaq.com‘s news article titled: “Mid-Morning Market Update: Markets Open Higher; Magna Tops Q1 Views” with publication date: May 10, 2018.

ARMO BioSciences, Inc. (NASDAQ:ARMO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: